Company

…”a division of Transgenic Pets”

The Company’s Board of Directors and officers bring together a strong mix of business acumen, scientific knowledge, and energy. The Advisory Panel is a mix of physicians, veterinarians and agribusinessman with a vast experience in animal and human health and business.

The People

Chairman/President: David Avner

Vice President: Jackie Avner

Director: Brett Richey

Director: Deborah Richey

In 1995, after several years of research in allergy and immunology, Dr. David Avner developed the idea of creating “allergen-free” pets through genetic engineering. Dr. Avner proposed to use gene and gene product targeting to “knock-out” or “suppress” known allergens at the cellular level. The resulting animals no longer produce or secrete the functional allergen.

Shortly thereafter, Dr. Avner submitted a patent application to the U.S. Patent and Trade Office which has been cleared of all prior art and paved the way for the development of allergen-free pets.

Transgenic Pets, LLC was crated in 2000 to explore the development of hypo-allergenic pets and other therapeutic applications of gene targeting in animals. Felix Pets, LLC a division of Transgenic Pets was incorporated in 2004 for the specific purpose of developing and selling allergen-free cats.

Felix Pets is currently negotiating a development agreement with one of the world’s premier genetic engineering institutes and hopes to continue development in early 2006.